Status:
TERMINATED
OMILQ: Osteopathic Manipulation to Increase Lactation Quantity (OMILQ)
Lead Sponsor:
AdventHealth
Conditions:
Osteopathic Manipulation
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
This study is designed to investigate whether using osteopathic manipulation can increase the milk supply in lactating women.
Detailed Description
The short and long-term benefits of breastfeeding to both the mother and infant are well established. Benefits for the child range from protection against common childhood infections, decreased rates ...
Eligibility Criteria
Inclusion
- Age 18 - 40
- Between 2 and 28 weeks postpartum from a live infant birth weighing at least 2500g
- Desire to exclusively breastfeed
- Able to provide informed consent
- Available for the duration of the study
- 1 hour milk volume of less than 1oz (or 2oz for twins)
- All current nurslings are the same age
Exclusion
- Current use of domperidone
- Current use of metoclopramide
- Current use of silymarin
- History of breast surgery
- Current malignancy
- Current pulmonary embolism or deep vein thrombosis
- Current medical condition resulting in increased intra-cranial pressure
- History of insufficient glandular tissue (IGT)
Key Trial Info
Start Date :
January 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2022
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03875794
Start Date
January 29 2019
End Date
April 15 2022
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AdventHealth East Orlando
Orlando, Florida, United States, 32822